keyword
https://read.qxmd.com/read/38702996/lag-3-recent-developments-in-combinational-therapies-in-cancer
#1
REVIEW
Aude Chavanton, Flavie Mialhe, Jimena Abrey, Alvaro Baeza Garcia, Carmen Garrido
The study of anticancer immune responses and in particular the action of immune checkpoint inhibitors that overcome T cell inhibition has revolutionized metastatic patients' care. Unfortunately, many patients are resistant to these innovative immunotherapies. Over the last decade, several immune checkpoint inhibitors, currently available in the clinic, have been developed, such as anti-PD-1/PD-L1 or anti-CTLA-4. More recently, other immune checkpoints have been characterized, among them lymphocyte activation gene 3 (LAG-3)...
May 4, 2024: Cancer Science
https://read.qxmd.com/read/38702938/linc00152-potential-driver-oncogene-in-pan-cancer
#2
REVIEW
Wei Xu, Huiting Li, Ziyao Wang, Yan Kang, Luojie Zheng, Yiping Liu, Ping Xu, Zheng Li
Long noncoding RNAs (lncRNA) are a class of non-coding RNAs greater than 200 bp in length with limited peptide-coding function. The transcription of LINC00152 is derived from chromosome 2p11.2. Many studies prove that LINC00152 influences the progression of various tumors via promoting the tumor cells malignant phenotype, chemoresistance, and immune escape. LINC00152 is regulated by multiple transcription factors and DNA hypomethylation. In addition, LINC00152 participates in the regulation of complex molecular signaling networks through epigenetic regulation, protein interactions, and competitive endogenous RNA (ceRNA)...
2024: Wiley Interdisciplinary Reviews. RNA
https://read.qxmd.com/read/38702922/immunization-adherence-among-children-with-sickle-cell-disease-and-sickle-cell-trait-results-of-a-population-based-study
#3
JOURNAL ARTICLE
Jiajing Scarlette Shi, Ankit Sutaria, Sangeetha Lakshmanan, Brandon Attell, Mei Zhou, Amy Tang, James Eckman, Angela Snyder
INTRODUCTION: Despite the importance of timely vaccine completion for protection from infectious disease, there is limited knowledge of the immunization adherence rates of children with sickle cell disease (SCD). METHODS: This is a retrospective cohort study comparing the immunization rates of children with SCD to those with sickle cell trait between 2008 and 2019 in Georgia. Completion rates for each vaccine and the proportion of children with up-to-date status at 24 and 35 months were calculated and compared between the cohorts...
May 3, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38702780/immune-checkpoint-inhibitors-induce-acute-interstitial-nephritis-in-mice-with-increased-urinary-mcp1-and-pd-1-glomerular-expression
#4
JOURNAL ARTICLE
Laura Martinez Valenzuela, Francisco Gómez-Preciado, Jordi Guiteras, Paula Antón Pampols, Montserrat Gomà, Xavier Fulladosa, Josep Maria Cruzado, Joan Torras, Juliana Draibe
INTRODUCTION: Immune checkpoint inhibitors (ICIs) induce acute interstitial nephritis (AIN) in 2-5% of patients, with a clearly higher incidence when they are combined with platinum derivatives. Unfortunately, suitable disease models and non-invasive biomarkers are lacking. To fill this gap in our understanding, we investigated the renal effects of cisplatin and anti-PD-L1 antibodies in mice, assessing PD-1 renal expression and cytokine levels in mice with AIN, and then we compared these findings with those in AIN-diagnosed cancer patients...
May 3, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38702734/drug-resistance-mechanisms-and-treatment-strategies-mediated-by-ubiquitin-specific-proteases-usps-in-cancers-new-directions-and-therapeutic-options
#5
REVIEW
Hongli Gao, Zhuo Xi, Jingwei Dai, Jinqi Xue, Xin Guan, Liang Zhao, Zhiguang Chen, Fei Xing
Drug resistance represents a significant obstacle in cancer treatment, underscoring the need for the discovery of novel therapeutic targets. Ubiquitin-specific proteases (USPs), a subclass of deubiquitinating enzymes, play a pivotal role in protein deubiquitination. As scientific research advances, USPs have been recognized as key regulators of drug resistance across a spectrum of treatment modalities, including chemotherapy, targeted therapy, immunotherapy, and radiotherapy. This comprehensive review examines the complex relationship between USPs and drug resistance mechanisms, focusing on specific treatment strategies and highlighting the influence of USPs on DNA damage repair, apoptosis, characteristics of cancer stem cells, immune evasion, and other crucial biological functions...
May 3, 2024: Molecular Cancer
https://read.qxmd.com/read/38702722/ferroptotic-therapy-in-cancer-benefits-side-effects-and-risks
#6
REVIEW
Jiandong Diao, Yuanyuan Jia, Enyong Dai, Jiao Liu, Rui Kang, Daolin Tang, Leng Han, Yingjie Zhong, Lingjun Meng
Ferroptosis is a type of regulated cell death characterized by iron accumulation and uncontrolled lipid peroxidation, leading to plasma membrane rupture and intracellular content release. Originally investigated as a targeted therapy for cancer cells carrying oncogenic RAS mutations, ferroptosis induction now exhibits potential to complement chemotherapy, immunotherapy, and radiotherapy in various cancer types. However, it can lead to side effects, including immune cell death, bone marrow impairment, liver and kidney damage, cachexia (severe weight loss and muscle wasting), and secondary tumorigenesis...
May 3, 2024: Molecular Cancer
https://read.qxmd.com/read/38702677/analyzing-the-expression-and-clinical-significance-of-cenpe-in-gastric-cancer
#7
JOURNAL ARTICLE
Jing Wang, Xiaofei Li, Xihui Qiang, Xueqing Yin, Lianyi Guo
BACKGROUND: Gastric cancer (GC) is a prevalent type of malignant gastrointestinal tumor. Many studies have shown that CENPE acts as an oncogene in some cancers. However, its expression level and clinical value in GC are not clear. METHODS: Obtaining clinical data information on gastric adenocarcinoma from TCGA and GEO databases. The gene expression profiling interaction analysis (GEPIA) was used to evaluate the relationship between prognosis and CENPE expression in gastric cancer patients...
May 3, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38702630/atypical-memory-b-cells-increase-in-the-peripheral-blood-of-patients-with-breast-cancer-regardless-of-lymph-node-involvement
#8
JOURNAL ARTICLE
Atefeh Azizi, Fereshteh Mehdipour, Morteza Samadi, Reza Rasolmali, Abdol-Rasoul Talei, Abbas Ghaderi
BACKGROUND: Breast cancer is the most common cancer in females. The immune system has a crucial role in the fight against cancer. B and T cells, the two main components of the adaptive immunity, are critical players that specifically target tumor cells. However, B cells, in contrast to T cells, and their role in cancer inhibition or progression is less investigated. Accordingly, in this study, we assessed and compared the frequency of naïve and different subsets of memory B cells in the peripheral blood of patients with breast cancer and healthy women...
May 3, 2024: BMC Immunology
https://read.qxmd.com/read/38702622/hindering-the-biofilm-of-microbial-pathogens-and-cancer-cell-lines-development-using-silver-nanoparticles-synthesized-by-epidermal-mucus-proteins-from-clarias-gariepinus
#9
JOURNAL ARTICLE
Ahmed N Alabssawy, Mohammed Abu-Elghait, Ahmad M Azab, Hassan M M Khalaf-Allah, Abdelrahman S Ashry, Ahmed O M Ali, Abu-Bakr A A Sabra, Salem S Salem
Scientists know very little about the mechanisms underlying fish skin mucus, despite the fact that it is a component of the immune system. Fish skin mucus is an important component of defence against invasive infections. Recently, Fish skin and its mucus are gaining interest among immunologists. Characterization was done on the obtained silver nanoparticles Ag combined with Clarias gariepinus catfish epidermal mucus proteins (EMP-Ag-NPs) through UV-vis, FTIR, XRD, TEM, and SEM. Ag-NPs ranged in size from 4 to 20 nm, spherical in form and the angles were 38...
May 4, 2024: BMC Biotechnology
https://read.qxmd.com/read/38702509/her2-targeting-car-t-cells-show-highly-efficient-anti-tumor-activity-against-glioblastoma-both-in-vitro-and-in-vivo
#10
JOURNAL ARTICLE
Xueying Li, Lifen Zhao, Wenzhe Li, Peng Gao, Nianzhu Zhang
Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. Current treatment options for GBM include surgical resection, radiation, and chemotherapy, which predominantly slow cancer growth and reduce symptoms, resulting in a 5-year survival rate of no more than 10%. Chimeric antigen receptor (CAR) T-cell therapy is a new class of cellular immunotherapy that has made great progress in treating malignant tumors. Human epidermal growth factor receptor 2 (HER2) is overexpressed in GBM and may provide a potential therapeutic target for GBM treatment...
May 3, 2024: Genes and Immunity
https://read.qxmd.com/read/38702460/linking-obesity-immune-dysfunction-and-cancer-risk
#11
JOURNAL ARTICLE
Alexandra Le Bras
No abstract text is available yet for this article.
May 2024: Lab Animal
https://read.qxmd.com/read/38702440/acetate-reprogrammes-tumour-metabolism-and-promotes-pd-l1-expression-and-immune-evasion-by-upregulating-c-myc
#12
JOURNAL ARTICLE
Juhong Wang, Yannan Yang, Fei Shao, Ying Meng, Dong Guo, Jie He, Zhimin Lu
Acetate, a precursor of acetyl-CoA, is instrumental in energy production, lipid synthesis and protein acetylation. However, whether acetate reprogrammes tumour metabolism and plays a role in tumour immune evasion remains unclear. Here, we show that acetate is the most abundant short-chain fatty acid in human non-small cell lung cancer tissues, with increased tumour-enriched acetate uptake. Acetate-derived acetyl-CoA induces c-Myc acetylation, which is mediated by the moonlighting function of the metabolic enzyme dihydrolipoamide S-acetyltransferase...
May 3, 2024: Nature metabolism
https://read.qxmd.com/read/38702396/the-evolving-treatment-landscape-of-metastatic-urothelial-cancer
#13
REVIEW
Giandomenico Roviello, Matteo Santoni, Guru P Sonpavde, Martina Catalano
Cisplatin-based chemotherapy is currently the first-line standard of care for patients with metastatic urothelial cancer (mUC); however, up to 50% of patients are ineligible for cisplatin, necessitating alternative treatment options. Immune checkpoint inhibitors have been shown to be effective in cisplatin-ineligible patients. However, despite advances in the first-line setting, the prognosis remains poor, and challenges persist in selecting optimal therapies, treatment sequences and combination regimens. Maintenance therapy with avelumab revealed improved overall (OS) and progression-free survival (PFS) compared with best supportive care alone in patients with platinum-responsive mUC...
May 3, 2024: Nature Reviews. Urology
https://read.qxmd.com/read/38702343/combination-therapy-with-oncolytic-virus-and-t-cells-or-mrna-vaccine-amplifies-antitumor-effects
#14
JOURNAL ARTICLE
Rao Fu, Ruoyao Qi, Hualong Xiong, Xing Lei, Yao Jiang, Jinhang He, Feng Chen, Liang Zhang, Dekui Qiu, Yiyi Chen, Meifeng Nie, Xueran Guo, Yuhe Zhu, Jinlei Zhang, Mingxi Yue, Jiali Cao, Guosong Wang, Yuqiong Que, Mujing Fang, Yingbin Wang, Yixin Chen, Tong Cheng, Shengxiang Ge, Jun Zhang, Quan Yuan, Tianying Zhang, Ningshao Xia
Antitumor therapies based on adoptively transferred T cells or oncolytic viruses have made significant progress in recent years, but the limited efficiency of their infiltration into solid tumors makes it difficult to achieve desired antitumor effects when used alone. In this study, an oncolytic virus (rVSV-LCMVG) that is not prone to induce virus-neutralizing antibodies was designed and combined with adoptively transferred T cells. By transforming the immunosuppressive tumor microenvironment into an immunosensitive one, in B16 tumor-bearing mice, combination therapy showed superior antitumor effects than monotherapy...
May 3, 2024: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/38702329/time-course-rnaseq-data-of-murine-ab1-mesothelioma-and-renca-renal-cancer-following-immune-checkpoint-therapy
#15
JOURNAL ARTICLE
Wee Loong Chin, Rachael M Zemek, Caitlin M Tilsed, Alistair R R Forrest, Vanessa S Fear, Catherine Forbes, Louis Boon, Anthony Bosco, Belinda B Guo, Michael J Millward, Anna K Nowak, Richard A Lake, W Joost Lesterhuis, Timo Lassmann
Time-critical transcriptional events in the immune microenvironment are important for response to immune checkpoint blockade (ICB), yet these events are difficult to characterise and remain incompletely understood. Here, we present whole tumor RNA sequencing data in the context of treatment with ICB in murine models of AB1 mesothelioma and Renca renal cell cancer. We sequenced 144 bulk RNAseq samples from these two cancer types across 4 time points prior and after treatment with ICB. We also performed single-cell sequencing on 12 samples of AB1 and Renca tumors an hour before ICB administration...
May 3, 2024: Scientific Data
https://read.qxmd.com/read/38702326/lncrna-il21-as1-facilitates-tumour-progression-by-enhancing-cd24-induced-phagocytosis-inhibition-and-tumorigenesis-in-ovarian-cancer
#16
JOURNAL ARTICLE
Jie Liu, Changsheng Yan, Shaohua Xu
CD24 is overexpressed in various tumours and considered a regulator of cell migration, invasion, and proliferation. Recent studies have found that CD24 on ovarian cancer (OC) and triple-negative breast cancer cells interacts with the inhibitory receptor sialic-acid-binding Ig-like lectin 10 (Siglec-10) on tumour-associated macrophages (TAMs) to inhibit phagocytosis by macrophages. Because of its multiple roles in regulating the immune response and tumorigenesis, CD24 is a very promising therapeutic target. However, the regulatory mechanism of CD24 in OC remains unclear...
May 3, 2024: Cell Death & Disease
https://read.qxmd.com/read/38702320/high-production-of-il-12-by-human-dendritic-cells-stimulated-with-combinations-of-pattern-recognition-receptor-agonists
#17
JOURNAL ARTICLE
Brian C Gilmour, Alexandre Corthay, Inger Øynebråten
The cytokine IL-12p70 is crucial for T helper 1 (Th1) polarization and the generation of type 1 immunity required to fight cancer and pathogens. Therefore, strategies to optimize the production of IL-12p70 by human dendritic cells (DCs) may significantly improve the efficacy of vaccines and immunotherapies. However, the rules governing the production of IL-12p70 remain obscure. Here, we stimulated pattern recognition receptors (PRRs) representing five families of PRRs, to evaluate their ability to elicit high production of IL-12p70 by monocyte-derived DCs...
May 3, 2024: NPJ Vaccines
https://read.qxmd.com/read/38702197/navigating-the-landscape-of-epitranscriptomics-and-host-immunity
#18
JOURNAL ARTICLE
Elaine Huang, Clara Frydman, Xinshu Xiao
RNA modifications, also termed epitranscriptomic marks, encompass chemical alterations to individual nucleotides, including processes such as methylation and editing. These marks contribute to a wide range of biological processes, many of which are related to host immune system defense. The functions of immune-related RNA modifications can be categorized into three main groups: regulation of immunogenic RNAs, control of genes involved in innate immune response, and facilitation of adaptive immunity. Here, we provide an overview of recent research findings that elucidate the contributions of RNA modifications to each of these processes...
May 3, 2024: Genome Research
https://read.qxmd.com/read/38702164/the-relevance-of-naturopathy-as-a-therapeutic-tool-in-the-modern-era-a-narrative-review
#19
JOURNAL ARTICLE
Sumnalata Ma Dewangan, Braj Bhushan Kumar
BACKGROUND: There are numerous reports of remarkable recoveries from diseases through drugless healing systems. In an effort to enhance the understanding of naturopathic therapies, the author, a renowned BNYS doctor specializing in naturopathy, yoga, nutrition, and wellness, aims to explain the importance of drugless therapies in various disease conditions. OBJECTIVE: To provide a comprehensive overview of the relevance and efficacy of naturopathy as a therapeutic tool in modern healthcare...
May 3, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38702147/phase-1-first-in-human-dose-escalation-study-of-anv419-in-patients-with-relapsed-refractory-advanced-solid-tumors
#20
JOURNAL ARTICLE
Laurent Mathiot, David Combarel, Justin Cagnat, Julia Delahousse, Kaissa Ouali, Aurelien Marabelle, Yohann Loriot, Santiago Ponce, Stephane Champiat, Sophie Broutin, Francois-Xavier Danlos
Patients with advanced cancer, previously treated with immune checkpoint blockade therapy, may retain residual treatment when undergoing the initial infusion of experimental monotherapy in phase 1 clinical trials. ANV419, an antibody-cytokine fusion protein, combines interleukin-2 (IL-2) with an anti-IL-2 monoclonal antibody, aiming to stimulate the expansion of CD8 T and natural killer lymphocytes while restricting regulatory T lymphocytes. In the recent publication of the phase 1 dose escalation study of ANV419, a notable gap exists in detailed information regarding patients' prior antitumoral treatments, specifically programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) targeted monoclonal antibodies...
May 3, 2024: Journal for Immunotherapy of Cancer
keyword
keyword
67096
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.